MedPath

The efficacy of Fesoterodine for the treatment of neurogenic detrusor overactivity and/or low-compliance bladder

Not Applicable
Conditions
eurogenic detrusor overactivity, Low compliance bladder
Registration Number
JPRN-UMIN000038269
Lead Sponsor
Dokkyo Medical University
Brief Summary

A total of 17 patients withdrew because of adverse events and so on. 60 patients completed the study. Bladder capacity at first desire to void, maximum cystometric capacity and bladder compliance increased significantly. Neurogenic detrusor overactivity disappeared in 23.5%, and a significant increase was observed in bladder capacity at first involuntary contraction, and a significant decrease was observed in maximum detrusor contraction.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
77
Inclusion Criteria

Not provided

Exclusion Criteria

Genitourinary tract anomalies, acute infection of the genitourinary tract or clinical relevant diseases of the kidneys; and any condition that in the opinion of the investigator made the patient unsuitable for the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath